Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest

Rhea-AI Summary

Cosmos Holdings (NASDAQ:COSM) announced its participation in the Virtual Growth Conference hosted by Maxim Group LLC on March 28-30, 2022, from 9:00 a.m. to 5:00 p.m. ET. Investors can access the Company's pre-recorded presentation over these three days. The event will cover various sectors, including Biotech, Clean Energy, and Healthcare, featuring presentations, fireside chats, and discussions with CEOs. Cosmos Holdings is an international pharmaceutical company specializing in nutraceuticals and distributing pharmaceuticals across Europe, Asia, and North America.

CHICAGO, IL / ACCESSWIRE / March 24, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced today that it will be presenting at the Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. ET.

This conference will be live on M-Vest and the Company's pre-recorded presentation will be available over the three days of the conference. Those who wish to attend the conference must first sign up to become an M-Vest member.

Click here to register.

During this virtual conference, investors will hear from executives from a wide range of sectors including Biotech, Clean Energy, Electric Vehicles, Financial Services, Fintech & REITS, Gaming & Entertainment, Healthcare, Healthcare IT, Infrastructure, Shipping and Technology/Media/Telecom. The conference will feature company presentations, fireside chats, and roundtable discussions with CEOs moderated by Maxim Research Analysts.

About Cosmos Holdings, Inc.

Cosmos Holdings Inc. (NASDAQ:COSM) is an international pharmaceutical company, with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices through an extensive, established EU distribution network. The Company identifies, acquires, develops and commercializes products that improve patients' lives and outcomes and has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com.

Forward-Looking Statements

With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic on the Company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Crescendo Communications, LLC
Tel: 212-671-1020
Email: COSM@crescendo-ir.com

SOURCE: Cosmos Holdings, Inc.

View source version on accesswire.com:
https://www.accesswire.com/694450/Cosmos-Holdings-to-Present-at-the-2022-Virtual-Growth-Conference-Presented-by-Maxim-Group-LLC-and-hosted-by-M-Vest

FAQ

When is Cosmos Holdings presenting at the Virtual Growth Conference?

Cosmos Holdings will present at the Virtual Growth Conference from March 28-30, 2022.

What is the purpose of the Virtual Growth Conference for Cosmos Holdings?

The conference allows Cosmos Holdings to showcase its business to investors through a pre-recorded presentation.

How can I attend the Virtual Growth Conference featuring Cosmos Holdings?

To attend, you must sign up to become an M-Vest member to access the conference.

What sectors will be discussed during the Virtual Growth Conference?

The conference will cover Biotech, Clean Energy, Electric Vehicles, and Healthcare, among other sectors.

What services does Cosmos Holdings provide?

Cosmos Holdings specializes in nutraceuticals and distributes branded and generic pharmaceuticals and medical devices.